HEADER TRANSLATION 27-JUL-23 8TLX TITLE CRYSTAL STRUCTURE OF MBP AND AF9 AHD FUSION PROTEIN 3AQA IN COMPLEX TITLE 2 WITH PEPTIDOMIMETIC INHIBITOR 21A COMPND MOL_ID: 1; COMPND 2 MOLECULE: MBP AND AF9 AHD FUSION PROTEIN 3AQA; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: PEPTIDOMIMETIC INHIBITOR 21A; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI K-12, HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 83333, 9606; SOURCE 5 STRAIN: K12; SOURCE 6 GENE: MALE, B4034, JW3994, MLLT3, AF9, YEATS3; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 12 ORGANISM_TAXID: 32630 KEYWDS MLL FUSION SUPER ELONGATION COMPLEX (SEC) ACUTE LYMPHOBLASTIC KEYWDS 2 LEUKEMIA ACUTE MYELOID LEUKEMIA, TRANSLATION EXPDTA X-RAY DIFFRACTION AUTHOR Y.YANG,Z.NIKOLOVSKA-COLESKA REVDAT 2 11-SEP-24 8TLX 1 REMARK DBREF SEQADV HELIX REVDAT 2 2 1 SHEET SSBOND ATOM REVDAT 1 29-MAY-24 8TLX 0 JRNL AUTH Y.YANG,E.AHMAD,V.PREMKUMAR,A.LIU,S.M.ASHIKUR RAHMAN, JRNL AUTH 2 Z.NIKOLOVSKA-COLESKA JRNL TITL STRUCTURAL STUDIES OF INTRINSICALLY DISORDERED MLL-FUSION JRNL TITL 2 PROTEIN AF9 IN COMPLEX WITH PEPTIDOMIMETIC INHIBITORS. JRNL REF PROTEIN SCI. V. 33 E5019 2024 JRNL REFN ESSN 1469-896X JRNL PMID 38747396 JRNL DOI 10.1002/PRO.5019 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.4 (17-FEB-2023) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 30402 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3070 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 51 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.11 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.57 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 609 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2387 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 560 REMARK 3 BIN R VALUE (WORKING SET) : 0.2329 REMARK 3 BIN FREE R VALUE : 0.3036 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.05 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3434 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 354 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.66800 REMARK 3 B22 (A**2) : 2.66800 REMARK 3 B33 (A**2) : -5.33610 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.240 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.225 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.177 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.202 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.170 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.933 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3592 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4896 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1251 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 617 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3592 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 485 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3379 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.92 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.13 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.25 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8TLX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1000276190. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.12704 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30466 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.097 REMARK 200 RESOLUTION RANGE LOW (A) : 200.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 11.00 REMARK 200 R MERGE (I) : 0.10500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 11.10 REMARK 200 R MERGE FOR SHELL (I) : 0.65900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-30% PEG3350 AND 0.1 M BIS-TRIS PH REMARK 280 5.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 86.09150 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 38.05050 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 38.05050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 43.04575 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 38.05050 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 38.05050 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 129.13725 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 38.05050 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 38.05050 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 43.04575 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 38.05050 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 38.05050 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 129.13725 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 86.09150 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2890 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A -2 REMARK 465 GLY A -1 REMARK 465 GLY A 0 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 2 NZ REMARK 470 LYS A 7 NZ REMARK 470 LYS A 26 CE NZ REMARK 470 LYS A 30 CD CE NZ REMARK 470 LYS A 35 CG CD CE NZ REMARK 470 LYS A 43 CE NZ REMARK 470 LYS A 47 CD CE NZ REMARK 470 LYS A 84 CD CE NZ REMARK 470 LYS A 128 CE NZ REMARK 470 LYS A 138 CD CE NZ REMARK 470 LYS A 143 CE NZ REMARK 470 TYR A 172 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 176 CG CD CE NZ REMARK 470 LYS A 203 CE NZ REMARK 470 LYS A 296 CD CE NZ REMARK 470 LYS A 298 NZ REMARK 470 GLU A 311 CG CD OE1 OE2 REMARK 470 GLN A 326 CD OE1 NE2 REMARK 470 ARG A 556 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 56 -169.36 -106.00 REMARK 500 ARG A 518 -30.61 -132.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1047 DISTANCE = 6.62 ANGSTROMS DBREF 8TLX A 2 367 UNP P0AEX9 MALE_ECOLI 27 392 DBREF 8TLX A 500 568 UNP P42568 AF9_HUMAN 500 568 DBREF 8TLX B 1 9 PDB 8TLX 8TLX 1 9 SEQADV 8TLX SER A -2 UNP P0AEX9 EXPRESSION TAG SEQADV 8TLX GLY A -1 UNP P0AEX9 EXPRESSION TAG SEQADV 8TLX GLY A 0 UNP P0AEX9 EXPRESSION TAG SEQADV 8TLX SER A 1 UNP P0AEX9 EXPRESSION TAG SEQADV 8TLX CYS A 336 UNP P0AEX9 GLN 361 ENGINEERED MUTATION SEQADV 8TLX ALA A 368 UNP P0AEX9 LINKER SEQADV 8TLX ALA A 369 UNP P0AEX9 LINKER SEQADV 8TLX ALA A 370 UNP P0AEX9 LINKER SEQADV 8TLX CYS A 502 UNP P42568 ALA 502 ENGINEERED MUTATION SEQRES 1 A 442 SER GLY GLY SER LYS ILE GLU GLU GLY LYS LEU VAL ILE SEQRES 2 A 442 TRP ILE ASN GLY ASP LYS GLY TYR ASN GLY LEU ALA GLU SEQRES 3 A 442 VAL GLY LYS LYS PHE GLU LYS ASP THR GLY ILE LYS VAL SEQRES 4 A 442 THR VAL GLU HIS PRO ASP LYS LEU GLU GLU LYS PHE PRO SEQRES 5 A 442 GLN VAL ALA ALA THR GLY ASP GLY PRO ASP ILE ILE PHE SEQRES 6 A 442 TRP ALA HIS ASP ARG PHE GLY GLY TYR ALA GLN SER GLY SEQRES 7 A 442 LEU LEU ALA GLU ILE THR PRO ASP LYS ALA PHE GLN ASP SEQRES 8 A 442 LYS LEU TYR PRO PHE THR TRP ASP ALA VAL ARG TYR ASN SEQRES 9 A 442 GLY LYS LEU ILE ALA TYR PRO ILE ALA VAL GLU ALA LEU SEQRES 10 A 442 SER LEU ILE TYR ASN LYS ASP LEU LEU PRO ASN PRO PRO SEQRES 11 A 442 LYS THR TRP GLU GLU ILE PRO ALA LEU ASP LYS GLU LEU SEQRES 12 A 442 LYS ALA LYS GLY LYS SER ALA LEU MET PHE ASN LEU GLN SEQRES 13 A 442 GLU PRO TYR PHE THR TRP PRO LEU ILE ALA ALA ASP GLY SEQRES 14 A 442 GLY TYR ALA PHE LYS TYR GLU ASN GLY LYS TYR ASP ILE SEQRES 15 A 442 LYS ASP VAL GLY VAL ASP ASN ALA GLY ALA LYS ALA GLY SEQRES 16 A 442 LEU THR PHE LEU VAL ASP LEU ILE LYS ASN LYS HIS MET SEQRES 17 A 442 ASN ALA ASP THR ASP TYR SER ILE ALA GLU ALA ALA PHE SEQRES 18 A 442 ASN LYS GLY GLU THR ALA MET THR ILE ASN GLY PRO TRP SEQRES 19 A 442 ALA TRP SER ASN ILE ASP THR SER LYS VAL ASN TYR GLY SEQRES 20 A 442 VAL THR VAL LEU PRO THR PHE LYS GLY GLN PRO SER LYS SEQRES 21 A 442 PRO PHE VAL GLY VAL LEU SER ALA GLY ILE ASN ALA ALA SEQRES 22 A 442 SER PRO ASN LYS GLU LEU ALA LYS GLU PHE LEU GLU ASN SEQRES 23 A 442 TYR LEU LEU THR ASP GLU GLY LEU GLU ALA VAL ASN LYS SEQRES 24 A 442 ASP LYS PRO LEU GLY ALA VAL ALA LEU LYS SER TYR GLU SEQRES 25 A 442 GLU GLU LEU ALA LYS ASP PRO ARG ILE ALA ALA THR MET SEQRES 26 A 442 GLU ASN ALA GLN LYS GLY GLU ILE MET PRO ASN ILE PRO SEQRES 27 A 442 CYS MET SER ALA PHE TRP TYR ALA VAL ARG THR ALA VAL SEQRES 28 A 442 ILE ASN ALA ALA SER GLY ARG GLN THR VAL ASP GLU ALA SEQRES 29 A 442 LEU LYS ASP ALA GLN THR ALA ALA ALA ASP LYS CYS TYR SEQRES 30 A 442 LEU ASP GLU LEU VAL GLU LEU HIS ARG ARG LEU MET THR SEQRES 31 A 442 LEU ARG GLU ARG HIS ILE LEU GLN GLN ILE VAL ASN LEU SEQRES 32 A 442 ILE GLU GLU THR GLY HIS PHE HIS ILE THR ASN THR THR SEQRES 33 A 442 PHE ASP PHE ASP LEU CYS SER LEU ASP LYS THR THR VAL SEQRES 34 A 442 ARG LYS LEU GLN SER TYR LEU GLU THR SER GLY THR SER SEQRES 1 B 9 ACY LEU PRO VAL DPP XYC PRO LEU NH2 HET ACY B 1 3 HET DPP B 5 6 HET XYC B 6 10 HET NH2 B 9 1 HET GLC C 1 12 HET GLC C 2 11 HET GOL A 601 6 HET GOL A 602 6 HET GOL B 101 6 HETNAM ACY ACETIC ACID HETNAM DPP DIAMINOPROPANOIC ACID HETNAM XYC (2~{S})-2-AZANYL-3-CYCLOPENTYL-PROPANOIC ACID HETNAM NH2 AMINO GROUP HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM GOL GLYCEROL HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 ACY C2 H4 O2 FORMUL 2 DPP C3 H8 N2 O2 FORMUL 2 XYC C8 H15 N O2 FORMUL 2 NH2 H2 N FORMUL 3 GLC 2(C6 H12 O6) FORMUL 4 GOL 3(C3 H8 O3) FORMUL 7 HOH *354(H2 O) HELIX 1 AA1 GLY A 17 GLY A 33 1 17 HELIX 2 AA2 LYS A 43 ALA A 53 1 11 HELIX 3 AA3 ARG A 67 SER A 74 1 8 HELIX 4 AA4 ASP A 83 ASP A 88 1 6 HELIX 5 AA5 TYR A 91 VAL A 98 1 8 HELIX 6 AA6 GLU A 132 LYS A 143 1 12 HELIX 7 AA7 GLU A 154 GLY A 167 1 14 HELIX 8 AA8 ASN A 186 ASN A 202 1 17 HELIX 9 AA9 ASP A 210 LYS A 220 1 11 HELIX 10 AB1 GLY A 229 TRP A 231 5 3 HELIX 11 AB2 ALA A 232 LYS A 240 1 9 HELIX 12 AB3 ASN A 273 TYR A 284 1 12 HELIX 13 AB4 THR A 287 LYS A 298 1 12 HELIX 14 AB5 LEU A 305 ALA A 313 1 9 HELIX 15 AB6 ASP A 315 GLY A 328 1 14 HELIX 16 AB7 CYS A 336 SER A 353 1 18 HELIX 17 AB8 THR A 357 LEU A 517 1 32 HELIX 18 AB9 GLU A 519 GLY A 534 1 16 HELIX 19 AC1 CYS A 548 LEU A 550 5 3 HELIX 20 AC2 ASP A 551 SER A 565 1 15 SHEET 1 AA1 6 VAL A 36 GLU A 39 0 SHEET 2 AA1 6 LEU A 8 TRP A 11 1 N LEU A 8 O THR A 37 SHEET 3 AA1 6 ILE A 60 ALA A 64 1 O ILE A 60 N TRP A 11 SHEET 4 AA1 6 PHE A 259 ILE A 267 -1 O GLY A 266 N ILE A 61 SHEET 5 AA1 6 TYR A 107 GLU A 112 -1 N ILE A 109 O LEU A 263 SHEET 6 AA1 6 ALA A 302 VAL A 303 -1 O ALA A 302 N VAL A 111 SHEET 1 AA2 5 VAL A 36 GLU A 39 0 SHEET 2 AA2 5 LEU A 8 TRP A 11 1 N LEU A 8 O THR A 37 SHEET 3 AA2 5 ILE A 60 ALA A 64 1 O ILE A 60 N TRP A 11 SHEET 4 AA2 5 PHE A 259 ILE A 267 -1 O GLY A 266 N ILE A 61 SHEET 5 AA2 5 GLU A 329 ILE A 330 1 O GLU A 329 N VAL A 260 SHEET 1 AA3 2 ARG A 99 TYR A 100 0 SHEET 2 AA3 2 LYS A 103 LEU A 104 -1 O LYS A 103 N TYR A 100 SHEET 1 AA4 3 MET A 225 ASN A 228 0 SHEET 2 AA4 3 SER A 115 ASN A 119 -1 N ILE A 117 O THR A 226 SHEET 3 AA4 3 TYR A 243 THR A 246 -1 O THR A 246 N LEU A 116 SHEET 1 AA5 2 PHE A 170 GLU A 173 0 SHEET 2 AA5 2 LYS A 176 ILE A 179 -1 O ASP A 178 N LYS A 171 SHEET 1 AA6 3 HIS A 537 ILE A 538 0 SHEET 2 AA6 3 THR A 542 ASP A 546 -1 O ASP A 544 N HIS A 537 SHEET 3 AA6 3 PRO B 3 PRO B 7 -1 O VAL B 4 N PHE A 545 SSBOND 1 CYS A 336 CYS A 502 1555 1555 2.04 LINK C ACY B 1 N LEU B 2 1555 1555 1.34 LINK C VAL B 4 N DPP B 5 1555 1555 1.34 LINK C DPP B 5 N XYC B 6 1555 1555 1.34 LINK C XYC B 6 N PRO B 7 1555 1555 1.35 LINK C LEU B 8 N NH2 B 9 1555 1555 1.32 LINK O4 GLC C 1 C1 GLC C 2 1555 1555 1.44 CRYST1 76.101 76.101 172.183 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013140 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013140 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005808 0.00000